Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Description
Kosmos is introduced as an advanced "AI Scientist" designed to autonomously engage in discovery by analyzing extensive scientific writings and running code to arrive at innovative insights. By employing structured world models, it effectively integrates knowledge acquired from numerous agent trajectories while ensuring consistency across tens of millions of tokens, thus overcoming the limitations in context length that previous language model-based systems faced. In a typical operational cycle, Kosmos can review around 1,500 research papers and execute 42,000 lines of analytical code, achieving in a single day what beta testers believe would require a human researcher six months to accomplish. Furthermore, the outputs generated by Kosmos are entirely traceable; every conclusion drawn in its reports can be directly linked to the exact lines of code and relevant literature excerpts that contributed to it, facilitating comprehensive scrutiny of its reasoning process. This level of transparency not only enhances credibility but also allows for deeper insights into the research methodology employed by Kosmos.
API Access
Has API
API Access
Has API
Integrations
Edison Analysis
GPT-5
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
$50 per month
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
BenevolentAI
Founded
2013
Country
Luxembourg
Website
www.benevolent.com
Vendor Details
Company Name
Edison Scientific
Founded
2025
Country
United States
Website
edisonscientific.com/articles/announcing-kosmos